Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis.
Alimoghadam S, Eslami A, Alimoghadam R, Bahrami Mianrood I, Azizmohammad Looha M, Khodadadi S, Shokouhi S, Alavi Darazam I. Alimoghadam S, et al. Among authors: alavi darazam i. J Glob Antimicrob Resist. 2024 Dec;39:159-169. doi: 10.1016/j.jgar.2024.08.014. Epub 2024 Sep 18. J Glob Antimicrob Resist. 2024. PMID: 39303871 Free article.
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up.
Salehi M, Alavi Darazam I, Nematollahi A, Alimohammadi M, Pouya S, Alimohammadi R, Khajavirad N, Porgoo M, Sedghi M, Mahdi Sepahi M, Azimi M, Hosseini H, Mahmoud Hashemi S, Dehghanizadeh S, Khoddami V. Salehi M, et al. Among authors: alavi darazam i. Int Immunopharmacol. 2024 Jun 15;134:112192. doi: 10.1016/j.intimp.2024.112192. Epub 2024 May 17. Int Immunopharmacol. 2024. PMID: 38761778 Clinical Trial.
Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis.
Javandoust Gharehbagh F, Roshanzamiri S, Farjami M, Hatami F, Lotfollahi L, Kazeminia N, Hatami F, Shokouhi S, Alavi Darazam I. Javandoust Gharehbagh F, et al. Among authors: alavi darazam i. J Oncol Pharm Pract. 2024 Jul;30(5):919-929. doi: 10.1177/10781552241241317. Epub 2024 May 8. J Oncol Pharm Pract. 2024. PMID: 38720564 Review.
The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial.
Sahraei Z, Panahi P, Solhjoukhah K, Mesbah M, Afaghi S, Amirdosara M, Salamzadeh J, Esmaeili Tarki F, Alavi Darazam I. Sahraei Z, et al. Among authors: alavi darazam i. Iran J Pharm Res. 2023 Aug 26;22(1):e137838. doi: 10.5812/ijpr-137838. eCollection 2023 Jan-Dec. Iran J Pharm Res. 2023. PMID: 38116548 Free PMC article.
Mpox vaccination and treatment: a systematic review.
Eslami A, Alimoghadam S, Khoshravesh S, Shirani M, Alimoghadam R, Alavi Darazam I. Eslami A, et al. Among authors: alavi darazam i. J Chemother. 2024 Apr;36(2):85-109. doi: 10.1080/1120009X.2023.2289270. Epub 2023 Dec 9. J Chemother. 2024. PMID: 38069596
Clinical and mycological implications of cryptococcal meningitis in Iran.
Bashardoust B, Alavi Darazam I, Daie Ghazvini R, Hashemi SJ, Salehi M, Abbasian L, Dehghan Manshadi SA, Abdorahimi M, Mohamadi A, Zamani F, Ardi P, Khodavaisy S. Bashardoust B, et al. Among authors: alavi darazam i. Heliyon. 2023 Oct 21;9(11):e21395. doi: 10.1016/j.heliyon.2023.e21395. eCollection 2023 Nov. Heliyon. 2023. PMID: 37908716 Free PMC article.
49 results